Results 91 to 100 of about 6,525 (155)

In vitro evaluation of Verteporfin and exploration of TEAD palmitoylation inhibition in Piezo1-YAP/TAZ signaling and ECM remodeling. [PDF]

Sci Rep
Xiaojun Z, Chen Q, Liu S, Liu B.
europepmc   +1 more source

Evaluation of Verteporfin as a Photosensitizer With Anticancer Activity Via System Biology Tools. [PDF]

J Lasers Med Sci
Ahmadzadeh A, Arjmand B, Razzaghi Z, Bandarian F, Rezaei M.   +4 more
europepmc   +1 more source

RETRACTED: SHP2 improved Late-onset fetal growth restriction via modulating ROS/BRD4/PI3K/YAP/PIGF signaling induced angiogenesis.

PLoS One
Li F, Li Y, Hao W, Zhang X, Shen X, Yang B, Zhang W, Fu L, Gu S.   +8 more
europepmc   +1 more source

Ten-year outcomes of intravitreal injection of ranibizumab for the treatment of myopic choroidal neovascularization. [PDF]

Medicine (Baltimore)
Kung YH, Peng KL, Shih LY, Wu TT.
europepmc   +1 more source

Fine-Tuning Photochemical Immunogenic Cell Death by a Panel of Verteporfin-Lipid Nanoparticles: A Data-Driven Approach. [PDF]

Small Sci
Shah N, Quaye MB, Soma SR, Vadlamudi MS, Mahmoud D, Malkoochi A, Aileni TR, Bhandari C, Karambelkar K, Hasan T, Korbelik M, Fei B, Song X, Obaid G.   +13 more
europepmc   +1 more source

FSCN1 induces subchondral bone sclerosis in osteoarthritis via modulating actin cytoskeleton dynamics and YAP signaling. [PDF]

Arthritis Res Ther
Xiao Y, Chen L, Chen D, Li J, Cheng Q, Yang P, Zou Z, Wu J, Li K, Yang C, Wang H, Yang C.   +11 more
europepmc   +1 more source

Verteporfin attenuates NLRP3 inflammasome activation to alleviate gout arthritis flares. [PDF]

J Inflamm (Lond)
Shippy DC, Ulland TK.
europepmc   +1 more source

Dysadherin/YAP axis fuels stem plasticity and immune escape in liver cancer. [PDF]

Signal Transduct Target Ther
Jang TY, Jeon SE, Yun HJ, Lee CJ, Lim DY, Lee SH, Lee D, Lee S, Choi J, Kim HS, Nam JS.   +10 more
europepmc   +1 more source

PANK4 Regulates YAP to Modulate the Glycolytic Pathway in LEC for Driving LECs-EMT in Early Diabetic Cataract Pathogenesis. [PDF]

Invest Ophthalmol Vis Sci
Li X, Luo L, Chen S, Sun Y, Li C, Liu X, Hu Q, Hu Z, Liu W, Liu T.   +9 more
europepmc   +1 more source

Outcomes of Treatment for Central Serous Chorioretinopathy With Half-Fluence, Half-Dose Photodynamic Therapy. [PDF]

J Vitreoretin Dis
Mishra AV, Deonarain DM, Loh GK, Tennant MTS.   +3 more
europepmc   +1 more source